Skip to main content
. Author manuscript; available in PMC: 2019 May 28.
Published in final edited form as: Epidemics. 2018 Aug 30;26:68–76. doi: 10.1016/j.epidem.2018.08.006

Table 3.

Results of MACS role analyses.

Role n Mean SPVL Pseudo-median SPVL (95% CI) p-value
All individuals El 46 4.28 4.36 (4.08–4.61) 0.371
 " ER or RV 328 4.29 4.36 (4.28–4.44)
6 mo. partner count ≤ 3 El 30 4.20 4.28 (3.89–4.69) 0.554
 " ER or RV 110 4.33 4.42 (4.29–4.53)
6 mo. partner count ≤ 10 El 39 4.22 4.31 (3.99–4.56) 0.488
 " ER or RV 253 4.26 4.34 (4.24–4.43)
30 mo. receptive partner count = 0 El 7 4.65 4.82 (4.04–5.05) 0.027
30 mo. receptive partner count ≤ 3 ER or RV 33 4.05 4.17 (3.79–4.45)
30 mo. receptive partner count = 0 El 7 4.65 4.82 (4.04–5.05) 0.024
30 mo. receptive partner count ≤ 10 ER or RV 91 4.19 4.28 (4.10–4.43)
30 mo. receptive partner count ≤ 3 El 17 4.49 4.67 (4.02–4.93) 0.039
 " ER or RV 33 4.05 4.17 (3.79–4.45)
30 mo. receptive partner count ≤ 10 El 20 4.51 4.68 (4.09–4.88) 0.017
 " ER or RV 91 4.19 4.28 (4.10–4.43)